What You Should Know:
- Waltz Health, a digital health company specializing in medication pricing and distribution, and Noom, a leader in digital health and chronic disease prevention, have announced a unique partnership to provide employers and health plans with a comprehensive and affordable weight loss program.
- The collaboration will leverage Waltz Connect, Waltz Health's innovative platform, to streamline access to GLP-1 medications, making them more accessible and
Read More
GLP-1
Dandelion Health Launches Clinical AI Marketplace + GLP-1 Study
What You Should Know:
- Dandelion Health, a real-world data (RWD) and clinical AI platform, today announced findings from a study that suggests GLP-1 medications may be effective in preventing cardiovascular disease (CVD) in a significantly larger population than previously thought.
- This research, conducted using validated AI on Dandelion's newly launched Clinical AI Marketplace, opens the door for a new era of precision medicine and personalized care in cardiometabolic
Read More
Noom Launches $149 GLP-1 Weight Loss Program with Sustainable Approach
What You Should Know:
- Noom, a digital healthcare company, is shaking up the weight loss industry with the launch of Noom GLP-1Rx, an innovative program offers affordable, accessible, and sustainable weight loss by combining compounded GLP-1 injections with Noom's proven behavioral change program.
- Noom GLP-1Rx delivers highly efficacious medications to the door within seven days starting at $149 and pairs those powerful medications with Noom GLP-1 Companion with Muscle
Read More
OMNY Health Launches GLP-1 Data Network to Advance Research
What You Should Know:
- OMNY Health, a healthcare ecosystem specializing in data partnerships, today announced the launch of its GLP-1 data network.
- The GLP-1 data network aims to democratize access to healthcare data and empower researchers, clinicians, and life sciences companies to gain valuable insights into GLP-1 therapies.
Addressing Data Gaps in GLP-1 Research
Despite the growing use of GLP-1 agonists, there remains a significant lack of comprehensive data on
Read More
Heart Health in the GLP-1 Era: The Role of Remote Patient Monitoring
According to the American Heart Association, nearly half of all adults in the U.S. have high blood pressure. Recent studies have suggested that effectively treating obesity with GLP-1 agonists may be key to improving overall heart health. These findings are promising — but additional study is necessary, further highlighting the need for accurate GLP-1 patient data and consistent at-home health monitoring.
Healthcare providers can benefit from high-precision remote monitoring tools like
Read More
FuturHealth Combines GLP-1 Medications with Personalized Nutrition
What You Should Know:
- FuturHealth, a leader in personalized weight-loss solutions launches its Custom Meal Plans. Designed to complement the growing popularity of GLP-1 medications, the new offering provides a comprehensive approach to weight management and long-term health.
- As the use of GLP-1 medications surges, FuturHealth recognizes the need for a holistic approach to weight loss. By combining personalized meal plans with medication, FuturHealth aims to help individuals
Read More
Patients Demand Personalized Obesity Care, New Survey Finds
What You Should Know:
- Phenomix Sciences, a precision medicine biotechnology company, released findings from a new survey revealing a growing demand for personalized obesity care.
- The survey of 475 patients explored attitudes toward weight management, treatment preferences, and information sources.
Key Findings:
Patients Seek Medical Guidance: A majority of respondents (66%) prefer guidance from healthcare providers to manage weight loss, highlighting the need for a
Read More
Physicians Reveals GLP-1s for Weight Loss are Overprescribed and Unsustainable
What You Should Know:
- A large majority of physicians feel GLP-1s are being overprescribed, according to a new survey from Virta Health, a leader in type 2 diabetes reversal.
- The Virta Health survey was conducted in partnership with Beresford Research and included 300 primary care providers, endocrinologists, and obesity specialists across the United States sheds light on the medical community's views on the rapidly growing class of GLP-1 medications, often hailed as
Read More
Nestlé Health Science Launches Innovative GLP-1 Nutrition Platform
What You Should Know:
- Nestlé Health Science, a global leader in nutritional science, today announced the launch of glp-1nutrition.com, a web platform designed to support individuals on their weight management journey, particularly those using GLP-1 medications.
- The launch of glp-1nutrition.com reflects their ongoing commitment to empowering healthier lives through targeted nutritional guidance.
GLP-1nutrition.com: Your One-Stop Shop for GLP-1 Weight Management Support
The
Read More
Aranscia and SignatureRX Partner to Optimize GLP-1 Medication Use
What You Should Know:
- Aranscia, a leader in personalized diagnostics, and Signature RX, a prominent pharmacy supplier, announced a collaborative effort to improve the effectiveness of GLP-1 medications.
- The multi-phase partnership focuses on developing personalized treatment plans and ensuring consistent access to these crucial medications.
GLP-1s: Beyond Type 2 Diabetes
Glucagon-like peptide-1 receptor agonists (GLP-1s) were initially developed for type 2 diabetes
Read More
